Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 24979-248

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 24979-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of bupropion hydrochloride showing a chlorophenyl ring bonded to a hydroxy ketone and a tert-butyl group, with an associated hydrochloride molecule. This diagram represents the molecular arrangement of the active ingredient bupropion hydrochloride.*

FDA Label Image

Label (Label)

Label for bupropion hydrochloride 450 mg extended-release tablets (XL), oral use, once daily dosing. The label lists the NDC 24979-248-06, and packaging includes 30 tablets. It provides usage directions, storage conditions, and manufacturer details including Pillar5 Pharma Inc. and distribution by TWi Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.